State-of-the Art Lecture
Symposium GI Oncology-2
Shaping the Future of Early GI Cancer Detection
Symposium Liver-2
Risk Stratification and Evolving Therapeutic Strategies in MASLD
Postgraduate Course-FGID/Motility
Current Trends in Functional Gastrointestinal Disorders
KSG-GEST Joint Symposium
The Next Frontier: AI-Powered Diagnosis and Treatment
KMA Mandatory Session
Medical Ethics in the Digital Era and Medical Disputes in the Field of Gastroenterology
Symposium FGID/Motility-2
Functional Dyspepsia 2026: From Pathophysiology to Management
Symposium Lower GI-2
Optimization of Diagnosis and Treatment of Colorectal Neoplasia
Postgraduate Course-Liver
Current Perspectives and Future Directions in Chronic Viral Hepatitis
UEG Educational Symposium
Practical Approaches to the Treatment of IBD
Symposium Lower GI-3
Key Issues in Nutrition for Lower GI Diseases: Insights from Various Perspectives
Educational Session-1
Liver, PB, GI Oncology
PA Education Session-I
From the Shadows into the Light
Symposium Pancreatobiliary-2
Navigating Biliary Strictures: From Imaging to Molecular Diagnosis and Therapeutic Innovation
Symposium Upper GI-3
Emerging Clinical Insights in Gastritis
Educational Session-2
Upper GI, Lower GI, FGID/Motility
MDT Session-2
Liver, PB, GI Oncology
PA Education Session-II
Key Point Lecture for PA
Abdominal US
Training for Beginners and Residents
Abdominal US
Hands-on Course for Residents and Fellows
Abdominal US
Training for Specialists 1
Abdominal US
Training for Specialists 2
Lawrence S. Kim, MD, AGAF, is the 120th President of the American Gastroenterological
Association (AGA) Institute for the 2025–2026 term. He officially began his presidency on May 28,
2025, succeeding Dr. Maria T. Abreu. As president, Dr. Kim has focused on several core
initiatives: 1) Inclusivity: Promoting a "message of inclusivity" for all gastroenterologists, regardless
of work setting (academic vs. private practice), 2) Independent Practice Advocacy: Supporting the
viability of independent GI practices and advocating for issues like Medicare reimbursement and
prior authorization reform. 3) Innovation: Strengthening the AGA's GI Opportunity Fund and venture
capital initiatives to invest in new technologies.
It is highly exceptional for a Korean-American physician to serve as President of the AGA, and
President Kim’s lecture will undoubtedly resonate deeply with our Korean gastroenterologists and
the broader audience. His talk, drawing on his career-long perspective on the evolution of
colorectal cancer screening and how our field continues to adapt, will deliver an inspiring and
timely message in Korea.
This lecture will provide an inspiring and timely message, offering valuable insights for
gastroenterologists, clinicians, and researchers seeking to stay at the forefront of colorectal
cancer prevention and care. Don’t miss this unique opportunity to learn from a global leader in
gastroenterology and colorectal cancer screening.
Yong Chan Lee, the chairman of the Korean Society of Gastroenterology (KSG), is a distinguished
gastroenterologist and academic leader in Korea, with extensive contributions to clinical practice,
research, and scholarly publishing in gastroenterology. He currently serves as Chairman of the
Korean Society of Gastroenterology and President of the Korean Society of Upper Gastrointestinal
Disorders and Helicobacter Research. Professor Lee also plays a key role in academic publishing
as Editor-in-Chief of Gut and Liver (SCIE-indexed journal) and as an editorial board member of
the Journal of Gastroenterology and Hepatology (SCI). In addition, he serves as Editorial Director
of the Korean Society of Neurogastroenterology and Motility, contributing to the advancement of
research and education in gastrointestinal motility disorders. Through his leadership in professional
societies and international journals, Professor Lee has significantly influenced the development of
gastroenterology research and clinical standards both in Korea and globally.
In this lecture, Professor Lee will explore the complex interplay between chronic inflammation, the
gastric microbiome, and gastric carcinogenesis, offering cutting-edge perspectives on disease
mechanisms and future clinical implications. Drawing on his extensive research experience and
leadership in international gastroenterology, this session promises to deliver valuable insights for
clinicians and researchers alike.
Do not miss this opportunity to gain a deeper understanding of the evolving role of the microbiome
in gastric cancer and its impact on prevention, diagnosis, and therapeutic strategies.